{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:09:46Z","timestamp":1794539386282,"version":"4.9.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270183"],"award-info":[{"award-number":["82270183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100241"],"award-info":[{"award-number":["82100241"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100247"],"award-info":[{"award-number":["82100247"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015640","name":"Tongji Hospital","doi-asserted-by":"publisher","award":["24-2KYC13060-23"],"award-info":[{"award-number":["24-2KYC13060-23"]}],"id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015640","name":"Tongji Hospital","doi-asserted-by":"publisher","award":["2024A30"],"award-info":[{"award-number":["2024A30"]}],"id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xcrm.2026.102584","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:40:22Z","timestamp":1770046822000},"page":"102584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy and safety of autologous CD5-KO anti-CD5 CAR-T cells in relapsed\/refractory CD5+ hematological malignancies"],"prefix":"10.1016","volume":"7","author":[{"given":"Jiali","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102584_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/323346a0","article-title":"Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1\/Leu-1","volume":"323","author":"Jones","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102584_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.immunol.20.100301.064833","article-title":"Origins and functions of B-1 cells with notes on the role of CD5","volume":"20","author":"Berland","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102584_bib3","doi-asserted-by":"crossref","DOI":"10.4161\/onci.22841","article-title":"T-cell modulatory properties of CD5 and its role in antitumor immune responses","volume":"2","author":"Tabbekh","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2026.102584_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg2752","article-title":"CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses","volume":"379","author":"He","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102584_bib5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/JLB.MR0618-226R","article-title":"The multiple faces of CD5","volume":"105","author":"Burgue\u00f1o-Bucio","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2026.102584_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood-2019-129559","article-title":"Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed\/Refractory T-Cell Malignancies","volume":"134","author":"Hill","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102584_bib7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102584_bib8","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.1016\/j.clml.2020.05.003","article-title":"De Novo CD5(+) Diffuse Large B-Cell Lymphoma: Biology, Mechanism, and Treatment Advances","volume":"20","author":"Xu","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.xcrm.2026.102584_bib9","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.ymthe.2021.07.001","article-title":"The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains","volume":"29","author":"Dai","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.102584_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adn6509","article-title":"CD5 deletion enhances the antitumor activity of adoptive T cell therapies","volume":"9","author":"Patel","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2026.102584_bib11","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1200\/JCO.2023.41.16_suppl.7002","article-title":"Enhanced anti-tumor activity of CD5 CAR T cells manufactured with tyrosine kinase inhibitors in patients with relapsed\/refractory T-ALL","volume":"41","author":"Hill","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102584_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41591-024-03282-2","article-title":"Allogeneic CD5-specific CAR-T therapy for relapsed\/refractory T-ALL: a phase 1 trial","volume":"31","author":"Pan","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102584_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41408-024-01082-y","article-title":"Anti-CD5 CAR-T cells with a tEGFR safety switch exhibit potent toxicity control","volume":"14","author":"Lin","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.xcrm.2026.102584_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1280007","article-title":"Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma","volume":"14","author":"Mu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102584_bib15","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2010-01-265041","article-title":"Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102584_bib16","article-title":"Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies","volume":"4","author":"Zhang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102584_bib17","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.1301721","article-title":"Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans","volume":"192","author":"Wertheimer","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102584_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12675","article-title":"Human CD8(+) EMRA T cells display a senescence-associated secretory phenotype regulated by p38 MAPK","volume":"17","author":"Callender","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.xcrm.2026.102584_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104507","article-title":"Cytotoxic CD161(-)CD8(+) T(EMRA) cells contribute to the pathogenesis of systemic lupus erythematosus","volume":"90","author":"Xiong","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2026.102584_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/eji.201948309","article-title":"CD5 blockade enhances ex vivo CD8(+) T cell activation and tumour cell cytotoxicity","volume":"50","author":"Alotaibi","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102584_bib21","first-page":"2460","article-title":"How I treat cytopenias after CAR T-cell therapy","volume":"141","author":"Jain","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102584_bib22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coi.2011.03.003","article-title":"The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease","volume":"23","author":"Soldevila","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.xcrm.2026.102584_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0090-1229(91)90016-4","article-title":"CD5+ B cells in autoimmune disease and lymphoid malignancy","volume":"59","author":"Shirai","year":"1991","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.xcrm.2026.102584_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100719","article-title":"An optimized protocol for the retroviral transduction of mouse CD4 T cells","volume":"2","author":"Eremenko","year":"2021","journal-title":"STAR Protoc."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:19:00Z","timestamp":1778919540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666379126000017"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102584","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of autologous CD5-KO anti-CD5 CAR-T cells in relapsed\/refractory CD5+ hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102584"}}